Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo
about
HIV-1 prophylactic vaccines: state of the artCan immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?Middle East respiratory syndrome: obstacles and prospects for vaccine developmentDNA and protein co-immunization improves the magnitude and longevity of humoral immune responses in macaquesDevelopments in HIV-1 immunotherapy and therapeutic vaccination.DNAVaxDB: the first web-based DNA vaccine database and its data analysis.Comparative analysis of enzymatically produced novel linear DNA constructs with plasmids for use as DNA vaccines.DNA vaccination by intradermal electroporation induces long-lasting immune responses in rhesus macaques.A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults.Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in SituOptimization of HIV-1 Envelope DNA Vaccine Candidates within Three Different Animal Models, Guinea Pigs, Rabbits and Cynomolgus MacaquesHIV DNA Vaccine: Stepwise Improvements Make a Difference.Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune PotentiatorsDose-dependent inhibition of Gag cellular immunity by Env in SIV/HIV DNA vaccinated macaquesImmunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45Plasmid DNA Vaccine Co-Immunisation Modulates Cellular and Humoral Immune Responses Induced by Intranasal Inoculation in Mice.Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challengeHER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model: Gene gun is superior to jet injector in inducing CTL responses and protective immunityDNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challengeSafety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype C vaccine boost in healthy adults.IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaquesIgA response and protection following nasal vaccination of chickens with Newcastle disease virus DNA vaccine nanoencapsulated with Ag@SiO2 hollow nanoparticles.DNA vaccines: roles against diseases.Vaccination with Vaxfectin(®) adjuvanted SIV DNA induces long-lasting humoral immune responses able to reduce SIVmac251 Viremia.Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques.Skin Transfection Patterns and Expression Kinetics of Electroporation-Enhanced Plasmid Delivery Using the CELLECTRA-3P, a Portable Next-Generation Dermal Electroporation DeviceFusion to the Lysosome Targeting Signal of the Invariant Chain Alters the Processing and Enhances the Immunogenicity of HIV-1 Reverse TranscriptaseTherapeutic and prophylactic DNA vaccines for HIV-1.DNA Immunization for HIV Vaccine Development.Nucleic acid vaccination strategies against infectious diseases.New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design.Antibody production by in vivo RNA transfection.DNA Vaccination by Electroporation Amplifies Broadly Cross-Restricted Public TCR Clonotypes Shared with HIV Controllers.IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells
P2860
Q26740042-229E4CDE-A7C9-4867-BA9D-C05EBA479C6AQ26865388-CB75F722-E3B8-4EF1-83B4-4F47F126C08CQ27013314-AD620C36-98ED-48FD-BA73-44C1C71AB6C4Q27316075-125E7880-BF22-43E8-9F9D-9B3E0662DDD8Q30364312-E1DEE28F-CA5B-4887-A431-1731AA72AF91Q30841376-A7C0D3FB-0CD5-4ED4-BECD-AD3219894C4AQ33847809-027F43D3-938A-44B5-B056-7D9F968E4A97Q34250318-973CEDE4-370B-460E-973A-D1535973EF13Q34369139-C33ECBAA-EE7B-4F4F-B437-F7FE51FE2EE1Q35826688-C5E9629D-21BF-4199-A15D-D385030CF93AQ35826692-344BDC0D-DFAA-43BF-B53C-8A276604C15BQ35826742-C29E7DE7-4CD8-4FC2-A4D9-9F405B639699Q35826747-55D42197-F26A-4075-85E1-B2F292E72309Q36256319-58B35261-3E34-43B5-811B-B99B9C9A1ECEQ36256428-0FC2C2D3-1997-4EAB-8266-01BEE18BDB61Q36257975-62630607-A02C-4E08-8B23-76F99675F476Q36258203-13094A2A-A43E-43E8-90C8-B2BB93ED91ABQ36476095-B4F75835-00D8-474E-B3D6-D1948303B7B1Q36637349-A0A04696-48E9-40BB-986D-F6917CF42DBDQ36668517-7D986684-7512-47BE-990F-7DAE486A08BCQ36694836-E96CEE9D-ED18-4F6A-BCD2-AA9E8707CAB5Q36893661-552ACFBF-478B-4087-91F1-07812EF2BF87Q37441566-369C9BEE-6C78-4CB1-9A8A-FE144781133CQ37530461-9116F246-EC26-4237-9EBB-4858F05B2EF9Q37530466-20F1BF42-4AA0-4217-9B98-2FABF80E7168Q37550619-687B6074-5D93-40B8-B5D3-9B35309826E8Q37722979-A2EA410F-C894-4657-AF7C-7746E9AB51B7Q38088037-6776BCD8-C4E2-405F-9F18-6C70FD0A0051Q38581981-3142CA40-0180-40EE-8E55-29B82410C2F7Q38586079-1FA663FB-CCCF-493C-B9D8-6C25544AADA4Q38748193-3A14399D-1ECC-4395-B112-DD5EAC6F2485Q40052131-ABA1245E-E8E9-4573-9152-E84DCA18AF24Q47619072-F6DBD027-3551-4FFD-86AD-0D7555F9FE34Q57117718-B21BE5CF-6FE7-4C05-81DA-D6F803DB4F3E
P2860
Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo
@en
Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo.
@nl
type
label
Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo
@en
Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo.
@nl
prefLabel
Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo
@en
Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo.
@nl
P2093
P2860
P1476
Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo
@en
P2093
Chaoran Billie Bian
David B Weiner
Devin J F Myles
Karuppiah Muthumani
Natalie A Hutnick
P2860
P304
P356
10.1016/J.COVIRO.2011.08.003
P577
2011-09-07T00:00:00Z